What is Terra?
Terra is a collaborative biomedical research platform co-developed by the Broad Institute of MIT and Harvard, Microsoft, and Verily, an Alphabet company. It provides researchers and data scientists with secure access to petabytes of biomedical data, enabling large-scale analysis workflows and cross-institutional collaboration. The platform is instrumental in supporting major scientific programs such as the NIH All of Us Research Program and the Human Cell Atlas. Terra's Data Custodian application facilitates the secure sharing of large clinico-genomic datasets while maintaining data sovereignty. With tens of thousands of researchers worldwide utilizing its infrastructure, Terra has facilitated over two billion core hours of compute, serving as a critical foundation for genomics, precision medicine, and collaborative discovery.
How much funding has Terra raised?
Terra has raised a total of $2.8M across 1 funding round:
Other Financing Round
$2.8M
Other Financing Round (2021): $2.8M with participation from Next Ventures, General Catalyst, and Samsung NEXT
Key Investors in Terra
Next Ventures
Next Ventures is a technology recruitment and professional services firm based in London, UK, established in 2001.
General Catalyst
General Catalyst is a venture capital firm that invests in transformational business opportunities across various sectors and stages, partnering with entrepreneurs to accelerate growth and build enduring enterprises.
Samsung NEXT
Samsung NEXT, founded in 2012, provides software and services to complement Samsung's global hardware, integrating product development, investment, M&A, and partnerships.
What's next for Terra?
The recent major strategic investment in Terra signals a strong confidence in its mission to democratize access to biomedical data and computational tools. As an enterprise-level funding recipient, Terra is poised to further scale its infrastructure, enhance its analytical capabilities, and foster deeper collaborations within the global research ecosystem. This strategic backing will likely enable the platform to support an even wider array of complex scientific endeavors, accelerating breakthroughs in precision medicine and disease research. The focus will remain on secure data access, robust workflow execution, and seamless collaboration across diverse institutions.
See full Terra company page
